Healthcare and Medical Device

The global clinical communication and collaboration market is on the cusp of significant growth, with revenue projected to reach $4.8 billion by 2029, growing at an impressive CAGR of 13.2% from 2024 to 2029. This expansion is driven by the numerous advantages these solutions offer in enhancing patient care and safety, the increasing demand for cost-containment measures within healthcare delivery systems, and the rising adoption of big data and mHealth tools. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=118830286 Key Drivers and Opportunities The primary driver for the market's growth lies in the ability of clinical communication solutions to streamline the flow of real-time health data, enabling continuous patient monitoring and minimizing errors through seamless communication among healthcare teams. The integration of these solutions with Electronic Health Records (EHRs) further enhances their value, facilitating informed decision-making a...

The global mental health screening market is on the cusp of substantial expansion, with revenue expected to surpass $1.8 billion by 2029, growing at an impressive CAGR of 12.2% from 2023 to 2029. In 2023, the market size was estimated at $0.9 billion. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198516770 Key Drivers and Trends: The market's growth is propelled by rising awareness of mental health issues, a heightened focus on remote monitoring solutions, and technological advancements in screening tools. Surveys indicate a notable shift in societal attitudes, with 82% of Americans now considering mental health as crucial as physical well-being, up from 68% in 2018. However, stigma surrounding mental illness persists as a restraining factor, with 44% of Americans experiencing discrimination due to their condition. Limited awareness about available screening resources also contributes to underutilization. Social media platforms present ...

The global tissue engineering market is projected to expand from $4.4 billion in 2023 to $8.9 billion by 2028, representing a strong CAGR of 15.3%. Key growth drivers include the rising need for advanced regenerative medicines to treat chronic and degenerative diseases, as well as increasing incidence of traumatic injuries from accidents. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34135173 While high treatment costs currently restrain market growth, exciting technological advancements like 3D bioprinting, organ-on-chip technology, and Quantum Magnetic Resonance Therapy (QMRT) present attractive future growth opportunities. Traditional organ transplants remain a more cost-effective alternative currently and are a challenge the industry must overcome. The tissue engineering ecosystem involves hospitals, clinics, technology providers, regulatory bodies, and collaborative networks all working together to advance tissue engineering solutions. Sca...

The global base editing market is experiencing remarkable growth, fueled by the rising prevalence of genetic diseases and the urgent need for precise gene editing technologies. Valued at $270 million in 2023, this market is projected to reach $549 million by 2028, expanding at an impressive compound annual growth rate (CAGR) of 15.2%. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21238371 Driving this growth is the increasing recognition of the role genetic mutations play in various diseases. As rare and orphan diseases become more prevalent, the demand for innovative therapies has skyrocketed, propelling base editing to the forefront of rare disease research and treatment. Base editing, a cutting-edge technology, offers a more precise alternative to traditional CRISPR-Cas9 methods, potentially minimizing off-target effects. However, ethical and safety concerns remain a significant barrier to its widespread adoption. The inadvertent modifications...

The global transdermal patches market is poised for significant expansion in the coming years, projected to grow from $6.2 billion in 2023 to $8.0 billion by 2029 at a compound annual growth rate (CAGR) of 4.5%. This burgeoning market is driven by several key factors, including the rising prevalence of chronic diseases, the increasing adoption of analgesic patches, technological advancements in transdermal patch development, and a shift away from traditional injections toward more convenient and patient-friendly transdermal delivery systems. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=190809043 One of the primary driving forces behind this growth is the growing popularity of analgesic patches for pain management. These patches offer a localized and controlled release of painkillers through the skin, reducing the risk of systemic adverse effects associated with oral medications. Patients with chronic pain disorders are increasingly turning to anal...

The global single-use bioprocessing market is experiencing explosive growth, projected to skyrocket from $8.2 billion in 2021 to $20.8 billion by 2026 at an impressive 20.5% compound annual growth rate (CAGR). This surge is fueled by the increasing demand for biopharmaceuticals, driven by an aging global population more susceptible to chronic conditions. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231651297 Single-use bioprocessing systems offer numerous advantages over traditional stainless-steel equipment, including greater energy efficiency, reduced water usage, smaller footprints, lower costs, quicker implementation, and diminished risk of cross-contamination. While concerns exist around extractables, leachables, and waste disposal, emerging markets in Asia like China and India present lucrative opportunities for this technology. Major players like Sartorius, Danaher's Cytiva, Thermo Fisher, and Merck are making massive investments to e...

The global adhesion barrier market is poised for significant growth, projected to expand from $0.7 billion in 2023 to $0.9 billion by 2028, at a compound annual growth rate (CAGR) of 7.4%. This upward trajectory is fueled by several key factors, including an aging global population, a surge in surgical procedures and sports-related injuries, and heightened awareness of adhesion formation complications. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208132543 Market Drivers and Challenges The primary driver propelling the adhesion barrier market's growth is the increasing volume of surgeries and sports-related injuries worldwide. Adhesion formation is a common post-surgical complication, often necessitating repeat surgeries for treatment. As the number of surgeries rises, so does the demand for effective adhesion barriers to mitigate these complications. However, the market faces a notable challenge: the reluctance of some surgeons to adopt a...

The global interventional oncology market is projected to experience robust growth in the coming years, driven by several key factors. Valued at $1.9 billion in 2020, this market is expected to reach $2.9 billion by 2026, growing at an impressive compound annual growth rate (CAGR) of 6.8%. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203687164 The Rise of Minimally Invasive Cancer Treatments A major driver of market growth is the increasing patient preference for minimally invasive procedures over traditional surgical methods. These advanced techniques offer numerous advantages, including fewer complications, shorter hospital stays, reduced pain and scarring, lower infection risks, and quicker recovery times. By leveraging cutting-edge technologies, interventional oncology enables precise tumor removal and tissue sampling for accurate cancer staging and treatment planning. Addressing the Skill Gap Despite the growing demand, a shortage of we...

The global oligonucleotide synthesis market is experiencing explosive growth, projected to surge from $8.8 billion in 2024 to a staggering $19.7 billion by 2029 at a compound annual growth rate of 17.5%. This meteoric rise is fueled by several key drivers. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350 Driving Forces Behind the Market's Ascent ·          Escalating use of synthesized oligonucleotides in therapeutic and diagnostic applications, harnessing their potential to tackle a diverse array of neurological disorders, rare diseases, and gene therapy. ·          Continuous technological advancements, such as next-generation sequencing (NGS) and the revolutionary CRISPR gene-editing tool, which are catalyzing demand for oligonucleotide synthesis. ·          Burgeoning investments from governments and major industry...

The global 3D cell culture market is experiencing significant growth, projected to reach $2.5 billion by 2028, expanding at a compound annual growth rate (CAGR) of 14.6% from 2023 to 2028. This growth is fueled by several key drivers and opportunities within the industry. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191072847 Driving Forces: 1. Alternatives to Animal Testing: One of the primary drivers is the increasing focus on developing alternatives to animal testing in pharmaceutical and scientific research. 3D cell culture models provide a more physiologically relevant and predictive platform for studying drug efficacy and toxicity, reducing the reliance on animal models. Regulatory bodies are encouraging the adoption of these advanced in vitro models, spurring growth in the 3D cell culture industry. 2. Personalized Medicine: The rising demand for personalized medicine has led to an increased need for 3D cell culture techniques. These mod...

The global patient handling equipment market is projected to experience robust growth in the coming years, driven by several key factors. According to recent estimates, this market was valued at $10.4 billion in 2022 and is expected to reach $14.0 billion by 2027, registering a compound annual growth rate (CAGR) of 6.2% during this period. The latest report on this market provides an updated overview, including assessments across all segments from 2020 to 2027. It also offers insights into industry trends, technology analysis, pricing analysis, and patent analysis. Additionally, the report considers the impact of the ongoing economic recession on market sizing and provides qualitative insights on its regional impact. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186358368 Fueling the growth of this market is a combination of factors, such as the growing number of geriatric and obese populations, the high risk of injuries to caregivers during ma...

The global enteral feeding devices market is experiencing remarkable growth, fueled by the increasing prevalence of chronic diseases and the aging population. Valued at $4.0 billion in 2023, this market is projected to reach $5.6 billion by 2029, growing at a robust compound annual growth rate (CAGR) of 6.2%. Enteral feeding devices play a crucial role in delivering essential nutrients directly into the digestive system, offering a lifeline to patients who cannot consume food orally due to various medical conditions. As the world's population ages and the incidence of chronic illnesses rises, the demand for these devices is soaring. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183623035 Driving Forces Behind the Growth The rapid growth of the geriatric population and the accompanying rise in age-related chronic diseases are the primary drivers of this market's expansion. With advances in healthcare and improved living standards, people...

The global protein expression market is expected to experience substantial growth in the coming years, projected to expand from $2.9 billion in 2022 to $5.4 billion by 2027 at a compound annual growth rate (CAGR) of 13.3%. This burgeoning market is driven by several key factors, including the increasing demand for protein biologics, particularly in the treatment of chronic diseases such as cancer, autoimmune disorders, and other serious conditions. As the life science and biopharmaceutical industries continue to thrive, the focus on recombinant protein expression and the availability of investments for protein-based research are providing further impetus to the market's growth. However, the high cost of protein expression reagents and instruments remains a restraining factor, potentially limiting adoption in certain areas. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180323924 One of the notable trends shaping the market is the emergence of ...

The market for Autoimmune Disease Diagnosis is experiencing rapid growth and is projected to expand from $4.1 billion in 2020 to $6.3 billion by 2025, increasing at an impressive 8.9% annual rate. Several key factors are fueling this market's expansion. Rising Autoimmune Disease Rates Drive Demand Perhaps the biggest driver is the high and increasing prevalence of autoimmune conditions like rheumatoid arthritis, lupus, Sjögren's syndrome and thyroiditis. As these diseases become more common, the need for accurate diagnostic tests grows correspondingly. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174826519 Greater Awareness Spurring Testing Along with higher disease rates, increased public and medical awareness about autoimmune disorders is prompting more patients to seek testing and diagnosis. Extensive research into understanding and treating these conditions is also contributing to market growth. Consumables Lead Product Segment...

The US healthcare/hospital food services market is witnessing robust expansion, projected to surge from $13.2 billion in 2021 to $22.8 billion by 2026, driven by a remarkable 11.5% compound annual growth rate (CAGR). This burgeoning market is fueled by several key factors, including the rising prevalence of chronic diseases, heightened awareness about the pivotal role of nutrition in healthcare, and a growing emphasis on enhancing the patient dining experience. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170935372 Chronic ailments such as heart disease, type 2 diabetes, and obesity have become increasingly prevalent, underscoring the urgent need for improved dietary practices. Hospitals and healthcare facilities are recognizing the transformative power of "food as medicine," prompting them to offer customized meal options tailored to diverse dietary requirements. Simultaneously, restrictions on outside food items and the cost-effectiven...

The global digital diabetes management market is experiencing meteoric growth, projected to soar from $18.9 billion in 2023 to a staggering $35.8 billion by 2028, at a compound annual growth rate (CAGR) of 13.6%. This burgeoning industry is driven by the ever-increasing prevalence of diabetes worldwide and the corresponding demand for innovative, technologically advanced solutions to manage this chronic condition effectively. Spearheading this revolution are groundbreaking advancements in artificial intelligence (AI) and connected devices. AI algorithms are revolutionizing diabetes care, enabling predictive models for risk assessment, optimizing resource utilization, and enhancing glycemic control. Pioneers like Medtronic, Abbott, and Dexcom are at the forefront of this AI-powered transformation, introducing cutting-edge devices such as artificial pancreas systems, continuous glucose monitoring (CGM) systems, and smart insulin pumps. Download a PDF Brochure: https://www.marketsand...

The global point of care molecular diagnostics market is experiencing rapid growth, projected to expand from $2.0 billion in 2023 to $3.4 billion by 2028 at a compound annual growth rate of 10.6%. This surge is being driven by the rising incidence of infectious diseases, cancer, and other acute and chronic conditions worldwide. As healthcare providers increasingly focus on improving facilities and infrastructure, demand for fast, accurate diagnostic testing at the point of care is escalating. However, uncertain reimbursement policies and a shortage of high-complexity testing facilities capable of performing point of care molecular diagnostics have posed obstacles to greater market penetration. Reimbursement remains a contentious issue, with Medicare revising payment mechanisms for certain in vitro diagnostic tests in recent years. Coverage policies can also limit testing for screening purposes in patients without an established condition. Download a PDF Brochure: https://www.marke...

The threat of antibiotic-resistant bacteria, often referred to as "superbugs," is a growing global health crisis. As these resilient pathogens continue to evade our most potent antimicrobial weapons, the need for robust surveillance systems has become increasingly critical. This emerging market is poised to play a vital role in monitoring and containing the spread of these formidable foes. Valued at $5.9 billion in 2023, the antimicrobial resistance (AMR) surveillance market is projected to reach $7.7 billion by 2028, growing at an impressive compound annual growth rate (CAGR) of 5.6%. Driven by the rising prevalence of infections caused by drug-resistant pathogens, such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and carbapenem-resistant Enterobacteriaceae (CRE), this market is poised to provide invaluable solutions for healthcare providers and public health authorities. Download a PDF Brochure: https://www.marketsandm...

The global diagnostic imaging services market is witnessing remarkable growth, projected to reach a staggering USD 702.6 billion by 2027, with a compound annual growth rate (CAGR) of 5.1%. This surge is fueled by several factors, including the rising prevalence of chronic diseases, an aging population, increasing awareness about advanced imaging procedures, and the rapid expansion of state-of-the-art diagnostic imaging centers. However, the market's growth is not without its challenges. The high costs associated with imaging technologies and the shortage of well-trained radiologists have emerged as significant barriers. The latter has led to an increase in turnaround times for imaging results, potentially impacting patient outcomes and hindering market growth. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17157849 Driving Forces and Opportunities The aging population is a significant driver of this market's growth. With the risk of deve...

The global market for optometry equipment is experiencing robust growth, projected to expand from $4.5 billion in 2024 to $6.1 billion by 2029 at a compound annual growth rate (CAGR) of 6.4%. This burgeoning industry is fueled by several key drivers, including an aging population, the rising prevalence of eye disorders, and continuous technological advancements in ophthalmic devices. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=14475790 A Closer Look at Market Dynamics The escalating incidence of eye conditions such as cataracts, glaucoma, and age-related macular degeneration is a primary catalyst propelling the demand for optometry equipment. As people grow older, particularly beyond the age of 60, the risk of these vision-impairing diseases increases, necessitating accurate diagnosis and treatment facilitated by advanced ophthalmic technologies. However, the high cost of optometry equipment and the adoption of refurbished devices pose a sign...